找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: COPD; Heterogeneity and Pe Sang-Do Lee Book 2017 Springer-Verlag Berlin Heidelberg 2017 ACOS.Assessment Tools.Heterogeneity of COPD.Persona

[復(fù)制鏈接]
查看: 38412|回復(fù): 35
樓主
發(fā)表于 2025-3-21 16:48:50 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱COPD
副標(biāo)題Heterogeneity and Pe
編輯Sang-Do Lee
視頻videohttp://file.papertrans.cn/221/220473/220473.mp4
概述Explains how analysis of the heterogeneity of COPD leads to improved, personalized treatment.Presents state of the art knowledge on a range of issues related to COPD heterogeneity.Describes an appropr
圖書封面Titlebook: COPD; Heterogeneity and Pe Sang-Do Lee Book 2017 Springer-Verlag Berlin Heidelberg 2017 ACOS.Assessment Tools.Heterogeneity of COPD.Persona
描述This book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.). Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous illustrations. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset in clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.
出版日期Book 2017
關(guān)鍵詞ACOS; Assessment Tools; Heterogeneity of COPD; Personalized Treatment; Pulmonary Hypertension; Diagnostic
版次1
doihttps://doi.org/10.1007/978-3-662-47178-4
isbn_softcover978-3-662-56892-7
isbn_ebook978-3-662-47178-4
copyrightSpringer-Verlag Berlin Heidelberg 2017
The information of publication is updating

書目名稱COPD影響因子(影響力)




書目名稱COPD影響因子(影響力)學(xué)科排名




書目名稱COPD網(wǎng)絡(luò)公開度




書目名稱COPD網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱COPD被引頻次




書目名稱COPD被引頻次學(xué)科排名




書目名稱COPD年度引用




書目名稱COPD年度引用學(xué)科排名




書目名稱COPD讀者反饋




書目名稱COPD讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:43:49 | 只看該作者
Definition and Epidemiology of COPDriteria instead of an LLN for the diagnosis of COPD [1]. Patients with COPD have shown a great deal of heterogeneity and can be classified according to their clinical and radiologic parameters, biomarkers, lung function impairment and prognosis [2]. Traditionally, COPD has been classified as chronic
板凳
發(fā)表于 2025-3-22 02:00:06 | 只看該作者
Book 2017he management of pulmonary hypertension and comorbidities. This book will be a great asset in clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.
地板
發(fā)表于 2025-3-22 04:59:37 | 只看該作者
ding bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset in clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.978-3-662-56892-7978-3-662-47178-4
5#
發(fā)表于 2025-3-22 11:52:36 | 只看該作者
6#
發(fā)表于 2025-3-22 15:47:44 | 只看該作者
of issues related to COPD heterogeneity.Describes an approprThis book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range o
7#
發(fā)表于 2025-3-22 18:51:35 | 只看該作者
8#
發(fā)表于 2025-3-22 23:56:32 | 只看該作者
Sang-Do LeeExplains how analysis of the heterogeneity of COPD leads to improved, personalized treatment.Presents state of the art knowledge on a range of issues related to COPD heterogeneity.Describes an appropr
9#
發(fā)表于 2025-3-23 02:21:50 | 只看該作者
http://image.papertrans.cn/c/image/220473.jpg
10#
發(fā)表于 2025-3-23 08:12:41 | 只看該作者
Family Campanulaceae (Lobeliaceae)ruction that is partially reversible but it is considered preventable and treatable disease now. Airflow limitation is associated with chronic and abnormal inflammatory response in the airways and the lung to noxious stimuli [1]. Airway obstruction is defined by a reduction of expiratory airflow. Ge
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 20:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
芦山县| 锡林郭勒盟| 祁门县| 唐海县| 剑河县| 新郑市| 阿瓦提县| 双江| 福州市| 临沭县| 宜城市| 南川市| 合作市| 太仆寺旗| 新巴尔虎左旗| 德昌县| 泸西县| 华坪县| 雷山县| 北票市| 峨眉山市| 开化县| 乌审旗| 邢台市| 柳州市| 光泽县| 固阳县| 百色市| 肥西县| 东乡族自治县| 通山县| 东乡县| 华亭县| 宁德市| 罗山县| 红原县| 西乌珠穆沁旗| 潜江市| 汝州市| 自治县| 大兴区|